BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
293.27
-11.35 (-3.73%)
At close: May 15, 2026, 4:00 PM EDT
298.00
+4.73 (1.61%)
After-hours: May 15, 2026, 7:46 PM EDT

BeOne Medicines AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32,60433,67819,71218,86222,94427,818
Market Cap Growth
19.54%70.85%4.51%-17.79%-17.52%17.53%
Enterprise Value
28,94731,05318,14716,58418,98121,873
Last Close Price
293.27303.81184.71180.36219.94270.93
PE Ratio
64.91123.00-30.23-21.34-11.35-17.22
Forward PE
42.2666.95----
PS Ratio
5.726.305.177.6716.2023.65
PB Ratio
6.807.725.925.335.234.54
P/TBV Ratio
7.067.905.845.325.184.10
P/FCF Ratio
27.6535.76-31.13-10.97-12.59-17.81
P/OCF Ratio
24.1229.87-140.17-16.30-15.33-21.42
EV/Sales Ratio
5.075.814.766.7413.4118.60
EV/EBITDA Ratio
35.2452.74-45.78-14.81-11.01-15.71
EV/EBIT Ratio
42.3469.45-31.94-13.73-10.61-15.20
EV/FCF Ratio
24.5532.97-28.66-9.65-10.42-14.01
Debt / Equity Ratio
0.410.440.320.260.130.11
Debt / EBITDA Ratio
2.463.40-2.72-0.83-0.35-0.50
Debt / FCF Ratio
1.842.12-1.70-0.54-0.33-0.44
Net Debt / Equity Ratio
-0.57-0.58-0.46-0.64-0.90-0.97
Net Debt / EBITDA Ratio
-3.28-4.333.902.012.294.25
Net Debt / FCF Ratio
-2.46-2.702.441.312.163.79
Asset Turnover
0.690.760.650.400.190.17
Inventory Turnover
1.041.211.301.091.090.99
Quick Ratio
3.162.961.491.963.214.44
Current Ratio
3.643.411.802.323.554.76
Return on Equity (ROE)
11.25%7.46%-18.77%-22.26%-38.11%-29.15%
Return on Assets (ROA)
6.42%4.36%-11.72%-21.17%-24.52%-20.63%
Return on Invested Capital (ROIC)
24.91%14.88%-37.20%-95.77%-167.83%-198.53%
Return on Capital Employed (ROCE)
10.47%8.88%-14.76%-27.12%-30.21%-25.11%
Earnings Yield
1.64%0.81%-3.31%-4.69%-8.81%-5.81%
FCF Yield
3.62%2.80%-3.21%-9.12%-7.94%-5.61%
Buyback Yield / Dilution
-10.10%-7.75%-0.86%-1.22%-11.15%-11.16%
Total Shareholder Return
-10.10%-7.75%-0.86%-1.22%-11.15%-11.16%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q